Swine Flu (H1N1) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
Condition: InfluenzaInterventions: Drug: AS03; Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179ASponsor: National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified January 2011 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2009 Category: Research Source Type: clinical trials

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza; Swine-origin A/H1N1 InfluenzaInterventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated); Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant); Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)Sponsors: Sanofi; Sanofi Pasteur, a Sanofi CompanyCompleted - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2009 Category: Research Source Type: clinical trials